Review




Structured Review

Moderna moderna bivalent covid 19 vaccine
Timeline for analysis of electronically identified ischemic stroke events among members aged <65 years of Kaiser Permanente Southern California who received Pfizer-BioNTech <t>bivalent</t> <t>COVID-19</t> and influenza vaccination during the period from September 1, 2022, to March 31, 2023.
Moderna Bivalent Covid 19 Vaccine, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+bivalent+covid+19+vaccine/bivalent/pmc13066344-98-54-54
Average 86 stars, based on 1 article reviews
moderna bivalent covid 19 vaccine - by Bioz Stars, 2026-10
86/100 stars

Images

1) Product Images from "A three-part model for the self-controlled case series design to estimate and characterize adverse event risk in an overlapping risk period after multiple vaccines: application to ischemic stroke following Pfizer-BioNTech bivalent COVID-19 vaccine and influenza vaccine"

Article Title: A three-part model for the self-controlled case series design to estimate and characterize adverse event risk in an overlapping risk period after multiple vaccines: application to ischemic stroke following Pfizer-BioNTech bivalent COVID-19 vaccine and influenza vaccine

Journal: American Journal of Epidemiology

doi: 10.1093/aje/kwaf115

Timeline for analysis of electronically identified ischemic stroke events among members aged <65 years of Kaiser Permanente Southern California who received Pfizer-BioNTech bivalent COVID-19 and influenza vaccination during the period from September 1, 2022, to March 31, 2023.
Figure Legend Snippet: Timeline for analysis of electronically identified ischemic stroke events among members aged <65 years of Kaiser Permanente Southern California who received Pfizer-BioNTech bivalent COVID-19 and influenza vaccination during the period from September 1, 2022, to March 31, 2023.

Techniques Used:

Related Articles

other:

Article Title: A three-part model for the self-controlled case series design to estimate and characterize adverse event risk in an overlapping risk period after multiple vaccines: application to ischemic stroke following Pfizer-BioNTech bivalent COVID-19 vaccine and influenza vaccine
Article Snippet: However, among Medicare beneficiaries who received a bivalent COVID-19 vaccine along with a high-dose or adjuvanted influenza vaccine, there was a significant association with nonhemorrhagic stroke within 22 to 42 days post-vaccination for the Pfizer-BioNTech bivalent COVID-19 vaccine and a significant association with transient ischemic attack within 1 to 21 days post-vaccination for the Moderna bivalent COVID-19 vaccine.



Similar Products

86
Moderna moderna bivalent covid 19 vaccine
Timeline for analysis of electronically identified ischemic stroke events among members aged <65 years of Kaiser Permanente Southern California who received Pfizer-BioNTech <t>bivalent</t> <t>COVID-19</t> and influenza vaccination during the period from September 1, 2022, to March 31, 2023.
Moderna Bivalent Covid 19 Vaccine, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+bivalent+covid+19+vaccine/bivalent/pmc13066344-98-54-54
Average 86 stars, based on 1 article reviews
moderna bivalent covid 19 vaccine - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

90
Moderna bivalent moderna covid-19 vaccine
Timeline of COVID-19 vaccine policy decisions.
Bivalent Moderna Covid 19 Vaccine, supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+bivalent+covid+19+vaccine/mrna+1273/pmc11893158-192-12-13
Average 90 stars, based on 1 article reviews
bivalent moderna covid-19 vaccine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Moderna covid-19 booster vaccine moderna bivalent original/omicron
Timeline of COVID-19 vaccine policy decisions.
Covid 19 Booster Vaccine Moderna Bivalent Original/Omicron, supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+bivalent+covid+19+vaccine/mrna+1273/pmc11752036__bmjopen___15___1___s001-64-22-25
Average 90 stars, based on 1 article reviews
covid-19 booster vaccine moderna bivalent original/omicron - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Moderna moderna/spikevax bivalent covid-19 vaccine
Timeline of COVID-19 vaccine policy decisions.
Moderna/Spikevax Bivalent Covid 19 Vaccine, supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+bivalent+covid+19+vaccine/mrna+1273/pmc11698282-92-3-3
Average 90 stars, based on 1 article reviews
moderna/spikevax bivalent covid-19 vaccine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Moderna bivalent covid-19 mrna vaccines moderna ba.4/5
Characteristics of adverse events reported to the COVID-19 vaccination management system in persons aged 18 years or older after vaccination with Pfizer and Moderna <t> bivalent mRNA vaccines </t>
Bivalent Covid 19 Mrna Vaccines Moderna Ba.4/5, supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+bivalent+covid+19+vaccine/bivalent+covid+19+mrna+vaccines+moderna+ba+4+5/pmc11700711-98-5-15
Average 90 stars, based on 1 article reviews
bivalent covid-19 mrna vaccines moderna ba.4/5 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Moderna bivalent covid-19 mrna vaccines moderna ba.1
Characteristics of adverse events reported to the COVID-19 vaccination management system in persons aged 18 years or older after vaccination with Pfizer and Moderna <t> bivalent mRNA vaccines </t>
Bivalent Covid 19 Mrna Vaccines Moderna Ba.1, supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+bivalent+covid+19+vaccine/bivalent+covid+19+mrna+vaccines+moderna+ba+1/pm39557576-26-5-15
Average 90 stars, based on 1 article reviews
bivalent covid-19 mrna vaccines moderna ba.1 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
BioNTech moderna pfizer-biontech bivalent covid-19 vaccines
Characteristics of adverse events reported to the COVID-19 vaccination management system in persons aged 18 years or older after vaccination with Pfizer and Moderna <t> bivalent mRNA vaccines </t>
Moderna Pfizer Biontech Bivalent Covid 19 Vaccines, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+bivalent+covid+19+vaccine/moderna+pfizer+biontech+bivalent+covid+19+vaccines/pm38140140-288-7-7
Average 90 stars, based on 1 article reviews
moderna pfizer-biontech bivalent covid-19 vaccines - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Moderna covid-19 vaccine moderna bivalent
Characteristics of adverse events reported to the COVID-19 vaccination management system in persons aged 18 years or older after vaccination with Pfizer and Moderna <t> bivalent mRNA vaccines </t>
Covid 19 Vaccine Moderna Bivalent, supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+bivalent+covid+19+vaccine/bivalent+moderna+mrna+vaccine/pm37608686-40-9-14
Average 90 stars, based on 1 article reviews
covid-19 vaccine moderna bivalent - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Moderna bivalent covid-19 vaccines (moderna)
Characteristics of adverse events reported to the COVID-19 vaccination management system in persons aged 18 years or older after vaccination with Pfizer and Moderna <t> bivalent mRNA vaccines </t>
Bivalent Covid 19 Vaccines (Moderna), supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+bivalent+covid+19+vaccine/mrna+1273/pm37828803-4785-38-41
Average 90 stars, based on 1 article reviews
bivalent covid-19 vaccines (moderna) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Timeline for analysis of electronically identified ischemic stroke events among members aged <65 years of Kaiser Permanente Southern California who received Pfizer-BioNTech bivalent COVID-19 and influenza vaccination during the period from September 1, 2022, to March 31, 2023.

Journal: American Journal of Epidemiology

Article Title: A three-part model for the self-controlled case series design to estimate and characterize adverse event risk in an overlapping risk period after multiple vaccines: application to ischemic stroke following Pfizer-BioNTech bivalent COVID-19 vaccine and influenza vaccine

doi: 10.1093/aje/kwaf115

Figure Lengend Snippet: Timeline for analysis of electronically identified ischemic stroke events among members aged <65 years of Kaiser Permanente Southern California who received Pfizer-BioNTech bivalent COVID-19 and influenza vaccination during the period from September 1, 2022, to March 31, 2023.

Article Snippet: However, among Medicare beneficiaries who received a bivalent COVID-19 vaccine along with a high-dose or adjuvanted influenza vaccine, there was a significant association with nonhemorrhagic stroke within 22 to 42 days post-vaccination for the Pfizer-BioNTech bivalent COVID-19 vaccine and a significant association with transient ischemic attack within 1 to 21 days post-vaccination for the Moderna bivalent COVID-19 vaccine.

Techniques:

Timeline of COVID-19 vaccine policy decisions.

Journal: Vaccine

Article Title: Development of COVID-19 vaccine policy — United States, 2020–2023 ☆

doi: 10.1016/j.vaccine.2023.12.022

Figure Lengend Snippet: Timeline of COVID-19 vaccine policy decisions.

Article Snippet: In December 2022, following changes to the FDA authorizations, CDC recommended a bivalent Moderna COVID-19 Vaccine booster dose for children ages 6 months–5 years; a third primary dose of bivalent Pfizer-BioNTech Vaccine for children ages 6 months–4 years was also recommended after receipt of 2 primary doses of monovalent Pfizer-BioNTech Vaccine[ ].

Techniques: Vaccines, Transmission Assay

Characteristics of adverse events reported to the COVID-19 vaccination management system in persons aged 18 years or older after vaccination with Pfizer and Moderna  bivalent mRNA vaccines

Journal: Osong Public Health and Research Perspectives

Article Title: Safety of the bivalent COVID-19 mRNA booster vaccination among persons aged over 18 years in the Republic of Korea

doi: 10.24171/j.phrp.2024.0194

Figure Lengend Snippet: Characteristics of adverse events reported to the COVID-19 vaccination management system in persons aged 18 years or older after vaccination with Pfizer and Moderna bivalent mRNA vaccines

Article Snippet: In Korea, the administration of bivalent COVID-19 mRNA vaccines started with the emergency approval of Moderna BA.1 (October 11, 2022), Pfizer BA.1 (November 7, 2022), Pfizer BA.4/5 (November 14, 2022), and Moderna BA.4/5 (December 26, 2022) [ , – ].

Techniques:

Types of symptoms and signs reported to the COVID-19 vaccination management system in persons aged 18 years and older after vaccination with Pfizer and Moderna  bivalent mRNA vaccines

Journal: Osong Public Health and Research Perspectives

Article Title: Safety of the bivalent COVID-19 mRNA booster vaccination among persons aged over 18 years in the Republic of Korea

doi: 10.24171/j.phrp.2024.0194

Figure Lengend Snippet: Types of symptoms and signs reported to the COVID-19 vaccination management system in persons aged 18 years and older after vaccination with Pfizer and Moderna bivalent mRNA vaccines

Article Snippet: In Korea, the administration of bivalent COVID-19 mRNA vaccines started with the emergency approval of Moderna BA.1 (October 11, 2022), Pfizer BA.1 (November 7, 2022), Pfizer BA.4/5 (November 14, 2022), and Moderna BA.4/5 (December 26, 2022) [ , – ].

Techniques: Injection, Coagulation